Taiyen Biotech Co., Ltd.

TWSE:1737 Voorraadrapport

Marktkapitalisatie: NT$6.5b

Taiyen Biotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Taiyen Biotech heeft een totaal eigen vermogen van NT$6.6B en een totale schuld van NT$194.8M, wat de schuld-eigenvermogensverhouding op 3% brengt. De totale activa en totale passiva bedragen respectievelijk NT$8.2B en NT$1.7B. De EBIT Taiyen Biotech is NT$303.5M waardoor de rentedekking -9.7 is. Het heeft contanten en kortetermijnbeleggingen van NT$1.8B.

Belangrijke informatie

3.0%

Verhouding schuld/eigen vermogen

NT$194.84m

Schuld

Rente dekkingsratio-9.7x
ContantNT$1.78b
AandelenNT$6.55b
Totaal verplichtingenNT$1.68b
Totaal activaNT$8.23b

Recente financiële gezondheidsupdates

Recent updates

Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Jul 31
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

May 09
Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Apr 24
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

Apr 09
Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Mar 25
A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Mar 12
Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Feb 01
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Jan 17
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

Jan 04
Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Dec 22
A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Dec 09
How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Nov 24
Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$2.8B ) 1737 } overtreffen de korte termijn passiva ( NT$1.0B ).

Langlopende schulden: De kortetermijnactiva 1737 ( NT$2.8B ) overtreffen de langetermijnschulden ( NT$653.6M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 1737 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 1737 is de afgelopen 5 jaar gestegen van 0.3% naar 3%.

Schuldendekking: De schuld van 1737 wordt goed gedekt door de operationele kasstroom ( 272.4% ).

Rentedekking: 1737 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven